6949 沛爾生醫-創本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | -111.76 | 684.00 |
| 2026/04 | -125.98 | 771.00 |
| 2026/03 | -91.67 | 561.00 |
| 2026/02 | -113.56 | 695.00 |
| 2026/01 | -98.04 | 600.00 |
| 2025/12 | -55.96 | 342.50 |
| 2025/11 | -62.42 | 382.00 |
| 2025/10 | -59.80 | 366.00 |
| 2025/09 | -66.91 | 409.50 |
| 2025/08 | -65.93 | 403.50 |
| 2025/07 | -29.38 | 193.00 |
| 2025/06 | -22.98 | 151.00 |
| 2025/05 | -20.70 | 136.00 |
| 2025/04 | -18.81 | 128.50 |
| 2025/03 | -20.94 | 143.00 |
| 2025/02 | -23.06 | 157.50 |
| 2025/01 | -5.76 | 79.00 |
| 2024/12 | -5.96 | 81.70 |
| 2024/11 | - | - |
| 2024/10 | -5.13 | 91.50 |
| 2024/09 | -4.53 | 80.80 |
| 2024/08 | -5.55 | 99.00 |
| 2024/07 | - | 113.50 |
| 2024/06 | - | 136.00 |
| 2024/05 | - | 130.50 |
| 2024/04 | - | 166.00 |
| 2024/03 | - | 81.40 |
| 2024/02 | - | - |
| 2024/01 | - | - |
| 2023/12 | - | - |
| 2023/11 | - | - |
| 2023/10 | - | - |
| 2023/09 | - | - |
| 2023/08 | - | - |
| 2023/07 | - | - |
| 2023/06 | - | - |
| 2023/05 | - | - |
| 2023/04 | - | - |
| 2023/03 | - | - |
| 2023/02 | - | - |
| 2023/01 | - | - |
| 2022/12 | - | - |
| 2022/11 | - | - |
| 2022/10 | - | - |
| 2022/09 | - | - |
| 2022/08 | - | - |
| 2022/07 | - | - |
| 2022/06 | - | - |
| 2022/05 | - | - |
| 2022/04 | - | - |
| 2022/03 | - | - |
| 2022/02 | - | - |
| 2022/01 | - | - |
| 2021/12 | - | - |
| 2021/11 | - | - |
| 2021/10 | - | - |
| 2021/09 | - | - |
| 2021/08 | - | - |
| 2021/07 | - | - |
| 2021/06 | - | - |
| 2021/05 | - | - |
| 2021/04 | - | - |
| 2021/03 | - | - |
| 2021/02 | - | - |
| 2021/01 | - | - |